期刊文献+

持续小剂量他达拉非早期治疗海绵体神经损伤后勃起功能障碍的实验研究 被引量:3

Effect of Early Continuous Low-dose Tadalafil on Erectile Dysfunction After Cavernous Nerve Injury in the Rats
暂未订购
导出
摘要 目的研究早期持续小剂量他达拉非应用对海绵体神经(CN)损伤后勃起功能障碍(ED)的作用。方法通过钳夹损伤CN方法建立神经性ED动物模型后,将大鼠分为治疗组、CN损伤组、假手术组、正常组。治疗组、CN损伤组均予钳夹损伤CN,假手术组仅暴露CN,正常组不作任何处理。治疗组大鼠手术当天即开始给予小剂量他达拉非2 mg.kg-1灌胃治疗,CN损伤组仅建立CN损伤后ED模型,不作任何治疗,假手术组仅对CN进行暴露,不作任何处理和治疗,正常组大鼠不作任何处理。术后4周行阿朴吗啡实验,电刺激盆腔星状神经节(MPG)前、后海绵体内压(ICP)/平均动脉压(MAP)测定,行阴茎海绵体nNOS免疫组化染色。结果阿朴吗啡实验:30 min内,治疗组50%的大鼠出现阴茎勃起,平均勃起(1.13±0.92)次;CN损伤组勃起率和勃起次数均为0;假手术组为100%和(2.03±0.97)次;正常组为100%和(2.36±1.02)次。治疗组阴茎勃起率及勃起次数均高于CN损伤组(P<0.05),仍较假手术组、正常组低(P<0.05)。治疗组电刺激后ICP/MAP明显较CN损伤组高(0.30±0.09 vs 0.12±0.05,P<0.05),仍明显较假手术组、正常组低(P<0.05)。治疗组nNOS阳性神经纤维数目明显较CN损伤组多(54.11±5.02 vs 21.34±3.17,P<0.05),仍明显较假手术组、正常组低(P<0.05)。结论早期持续小剂量他达拉非治疗大鼠CN损伤后ED,有助于勃起功能的恢复。 Objective To investigate the effect of early continuous administration of tadalafil on erectile dysfunction after cavernous nerve injury in the rat model. Methods The erectile dysfunction (ED) animal model was established by clamping the rats cavemous nerve(CN). Rats were divided into four groups: treatment, CN injured, sham operated and normal control. Rats in the treatment group were given with tadalafil daily at a low dose of 2 mg· kg^-1 intragastrically. Rats in sham operated group had the CN exposed without clamping or any treatment. Four weeks after the operation, the apomorphine test was used to assess erectile function by measuring maximum intracavernosal pressure (ICP)/mean arterial pressure (MAP) ratio before and after major pelvic ganglion (MPG) electrical stimulation. The mid-shaft tissue of penes was taken for histological analysis, and immunohistochemical antibody staining was used to detect nNOS and the number of nNOS-positive nerve fibers. Results Penile erection was observed in 50% (6/12) of the rats for an average of (1.13±0.92) times within 30 min in the treatment group, as compared with 0% (0/11 ) of the rats with (0.00±0.00) times in the CN injured group ( P〈0.05 ), and 100% (10/10) of the rats for (2.03+0.97) times in the sham group (P〈0.05), and 100% (10/10) of the rats for (2.36±1.02) times in normal group (P〈0.05). No significant differences were manifested in ICP/MAP ratio before MPG electrical stimulation in the 4 groups. However, the ICP/MAP ratio of the treatment group was significantly higher than that of the CN injured group (P〈0.05) after MPG electrical stimulation, but lower than that of the sham group ( P〈0.05 ) and normal group (P〈0.05). The number of nNOS-positive nerve fibers was significantly higher in the treatment group than that in CN injured group (54.11 ±5.02 vs 21.34±3.17, P〈0.05 ), but significantly lower than that of sham group (76.48±8.24, P〈0.05 ) and normal group (81.09±7.25, P〈0.05 ). Conclusion Early low-dose administration of tadalafil after cavernous nerve injury restores erectile function.
出处 《医药导报》 CAS 北大核心 2013年第7期873-877,共5页 Herald of Medicine
基金 国家自然科学基金青年科学基金资助项目(30901487) 广东省自然科学基金资助项目(2008B030301059) 广东省医学科研基金资助项目(A2010360)
关键词 他达拉非 海绵体神经 勃起功能障碍 前列腺癌根治术 Tadalafil Cavernous nerve Erectile dysfunction Radical prostatectomy
  • 相关文献

参考文献18

  • 1WALSH P C. Sexual function and bother after radical pros- tatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE [ J ]. J Urol, 2000, 163( 1 ) :370.
  • 2ALIVIZATOS G,SKOLARIKOS A. Incontinence and erec- tile dysfunction following radical prostatectomy: a review [J]. Sci Worht J,2005,5(5) :747-758.
  • 3MAY F, VROEMEN M, MATIASEK K, et al. Nerve repla- cement strategied for cavernous nerves[ J]. Eur Urol,2005, 48(3) :372-378.
  • 4ANASTASIADIS A G, BENSON M C, ROSENWASSER M P,et al. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible[ J 1- Prostate Cancer Prostatic Dis, 2003,6 ( 1 ) : 56-60.
  • 5WALSH P C. The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatcctomy [ J ]. J Urol, 2007,177 ( 5 ) : 1632-1635.
  • 6HEMANDEZ D J,EPSTEIN J I,TROCK B J,et al. Radical retropubic prostatectomy:how often do experienced surgeons have positive surgical margins when there is extraprostatie extension in the region of the neurovaseular bundle? [J]. JUrol,2005,174 ( 2 ) : 789-790.
  • 7林桂亭,Tom F Lue,Ching-Shwun Lin.阴茎勃起神经再生模型和机制的研究[J].中华男科学杂志,2007,13(12):1059-1063. 被引量:7
  • 8QUINLAN D M, NELSON R J, PARTIN A W,et al. The rat as a model for the study of penile erection [ J ]. J Urol, 1989,141 (3) :656-661.
  • 9KAOUK J H, DESAI M M,ABREU S C,et al. Robotic assisted laparoscopic sural nerve grafting during radical prostatectomy: initial experience [ J ]. J Urol, 2003, 170 (3) :909-912.
  • 10TAKENAKA A, MURAKAMI G, SOGA H, et al. Anato- mical analysis of the neurovascular bundle supplying penile cavernous tissue to ensure a reliable nerve graft after radical prostatectomy [ J ]. J Ur01,2004,172 ( 3 ) : 1032-1035.

二级参考文献21

  • 1Burnett, AL. Erectile dysfunction[J]. J Urol,2006, 175(3 Pt 2) : S25-S31.
  • 2Kendirei, M, Bejma J, Hellstrom W J. Update on erectile dysfunction in prostate cancer patients [ J ]. Curt Opin Urol, 2006, 16(3) : 186-195.
  • 3Crawford ED, Bennett CL, Stone NN, et al. Comparison of perspectives on prostate cancer: analyses of survey data [ J ]. Urology, 1997, 50(3): 366-372.
  • 4Penson DF, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study [ J ]. J Clin Oncol, 2003,21 (6) : 1147-1154.
  • 5Kendirci M, Hellstrom WJ. Current concepts in the management of erectile dysfunction in men with prostate cancer[ J ]. Clin Prostate Cancer,2004, 3(2) : 87-92.
  • 6Leungwattanakij S, Bivalacqua TJ, Usta MF, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum [J]. J Androl, 2003,24(2):239-245.
  • 7McVary K. Lower urinary tract symptoms and sexual dysfunction : epidemiology and pathophysiology [ J ]. BJU Int, 2006, 97 (Suppl 2) : 23-28.
  • 8Musicki B, Bumett AL. Endothelial dysfunction in diabetic erectile dysfunction[J]. Int J Impot Res,2007,19(2) :129-138.
  • 9Papatsoris AG, Deliveliotis C, Singer C, et al. Erectile dysfunction in Parkinsons disease [J]. Urology, 2006, 67(3) : 447- 451.
  • 10Lin G, Chen KC, Hsieh PS, et al. Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia [J]. BJU Int, 2003, 92(6) :631-635.

共引文献12

同被引文献28

  • 1Zippe CD,Pahlajani G.Penile rehabilitation following radical prostatectomy:role of early intervention and chronic therapy.Urol Clin North Am,2007,34(4):601-18.
  • 2Salonia A,Burnett AL,Graefen M,et al.Prevention and management of postprostatectomy sexual dysfunctions part2:recovery and preservation of erectile function,sexual desire,and orgasmic function.Eur Urol,2012,62(2):273-286.
  • 3Defade BP,Carson CC,Kennelly MJ.Postprostatectomy erectile dysfunction:the role of penile rehabilitation.Rev Urol,2011,13(1):6-13.
  • 4Raina R,Lakin MM,Agarwal A,et al.Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy:3-year follow-up.Urology,2003,62(1):110–115.
  • 5Lagoda G,Sezen SF,Liu T,et al.FK506-binding protein localizations in human penile innervation.BJU Int,2008,101(5):604-609.
  • 6Aydogdu O,Gokce MI,Burgu B,et al.Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy.Int Braz J Urol,2011,37(3):336-44.
  • 7Porst H,Rajfer J,Casabe A,et al.Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction.J Sex Med,2008,5(9):2160-2169.
  • 8Porst H,Giuliano F,Glina S,et al.Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction:results of a multicenter,randomized,double-blind,placebo-controlled trial.Eur Urol,2006,50(2):351-359.
  • 9Kang DH,Lee JY,Park SY,et al.Efficacy and safety of tadalafil 5mg administered once daily in Korean men with erectile dysfunction:a prospective,multicenter study.Korean J Urol,2010,51(9):647-652.
  • 10Yuan J,Zhang R,Yang Z,et al.Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction:a systematic review and network meta-analysis.Eur Urol,2013,63(5):902-912.

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部